Search details
1.
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Lancet Oncol
; 22(8): 1115-1125, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34246328
2.
Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children.
Pediatr Blood Cancer
; 68(7): e29056, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33844446
3.
Alpha-emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor.
Pediatr Blood Cancer
; 71(6): e30961, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38556730
4.
Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States.
J Nucl Med
; 65(5): 746-752, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38514088
5.
Targeted α-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial.
J Nucl Med
; 63(9): 1326-1333, 2022 09.
Article
in English
| MEDLINE | ID: mdl-34992153
6.
Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [64Cu]Cu-DOTA-TOC.
Cancers (Basel)
; 14(8)2022 Apr 10.
Article
in English
| MEDLINE | ID: mdl-35454822
7.
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
J Nucl Med
; 63(2): 226-232, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34049987
8.
64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial.
J Nucl Med
; 61(6): 890-896, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31924723
9.
Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study.
Eur Urol
; 78(2): 148-154, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32532512
10.
Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model.
Mol Cancer Ther
; 18(5): 1012-1021, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30926632
11.
Toward Integrated Independence: Johannes Czernin Discusses the Future of Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber.
J Nucl Med
; 64(9): 1361-1363, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37591543
12.
Safety and Effectiveness of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy After Regional Hepatic Embolization in Patients With Somatostatin-Expressing Neuroendocrine Tumors.
Clin Nucl Med
; 42(11): 822-828, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28832377
13.
Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate in Patients With Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years' Assessment.
Clin Nucl Med
; 42(6): 436-443, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28263217
14.
Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy.
J Clin Oncol
; 20(3): 688-93, 2002 Feb 01.
Article
in English
| MEDLINE | ID: mdl-11821449
15.
Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
Clin Nucl Med
; 30(1): 11-5, 2005 Jan.
Article
in English
| MEDLINE | ID: mdl-15604959
16.
Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.
Am J Nucl Med Mol Imaging
; 5(1): 65-71, 2015.
Article
in English
| MEDLINE | ID: mdl-25625028
17.
Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues.
Cancer Treat Rev
; 30(2): 165-72, 2004 Apr.
Article
in English
| MEDLINE | ID: mdl-15023434
18.
Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
Surgery
; 132(6): 968-74; discussion 974-5, 2002 Dec.
Article
in English
| MEDLINE | ID: mdl-12490843
19.
Potential role for intraoperative gamma probe identification of normal parathyroid glands.
Am J Surg
; 186(6): 711-7, 2003 Dec.
Article
in English
| MEDLINE | ID: mdl-14672784
20.
The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.
Am J Nucl Med Mol Imaging
; 4(5): 426-34, 2014.
Article
in English
| MEDLINE | ID: mdl-25143861